Vanguard Group Inc Rapt Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,941,349 shares of RAPT stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,941,349

Previous 3,156,005 6.8%

Holding current value

$3.68 Million

Previous $6.34 Million 26.74%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.81 - $3.1 $173,871 - $665,433	-214,656 Reduced 6.8%	2,941,349 $4.65 Million
Q3 2024 Nov 13, 2024	BUY	$1.76 - $3.75 $84,017 - $179,013	47,737 Added 1.54%	3,156,005 $6.34 Million
Q2 2024 Aug 13, 2024	BUY	$2.89 - $9.38 $1.78 Million - $5.77 Million	615,418 Added 24.69%	3,108,268 $9.48 Million
Q1 2024 May 10, 2024	BUY	$6.87 - $26.45 $3 Million - $11.5 Million	436,629 Added 21.23%	2,492,850 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $371,292 - $838,041	32,916 Added 1.63%	2,056,221 $51.1 Million
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $1.25 Million - $1.88 Million	76,356 Added 3.92%	2,023,305 $33.6 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $5.87 Million - $7.9 Million	365,431 Added 23.11%	1,946,949 $36.4 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $1.28 Million - $2.29 Million	74,345 Added 4.93%	1,581,518 $29 Million
Q4 2022 Feb 10, 2023	BUY	$16.28 - $24.6 $3.63 Million - $5.49 Million	223,265 Added 17.39%	1,507,173 $29.8 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $329,799 - $559,336	18,363 Added 1.45%	1,283,908 $30.9 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $420,660 - $967,190	41,000 Added 3.35%	1,265,545 $23.1 Million
Q1 2022 May 13, 2022	BUY	$17.02 - $40.22 $309,644 - $731,722	18,193 Added 1.51%	1,224,545 $26.9 Million
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $3.76 Million - $5.03 Million	127,466 Added 11.81%	1,206,352 $44.3 Million
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $4.93 Million - $6.51 Million	164,970 Added 18.05%	1,078,886 $33.5 Million
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $16.4 Million - $36.6 Million	913,916 New	913,916 $29.1 Million

Others Institutions Holding RAPT

# of Institutions

100

Shares Held

124M

Call Options Held

246K

Put Options Held

69.6K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $37.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Rapt Therapeutics, Inc. Transaction History